# Medtronic PLC (MDT)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $104.15B  
**Price:** $80.74 (+0.61%)

> Medtronic plc is a global medical technology company that develops, manufactures, and sells device-based therapies and related services for a broad range of chronic and acute health conditions. Headquartered in Dublin, Ireland, and founded in 1949, Medtronic focuses on technologies used by hospitals, clinics, and physicians worldwide. The company operates through four main areas: its Cardiovascular Portfolio, offering products such as heart valves, stents, pacemakers, and defibrillators; its Neuroscience Portfolio, which provides spinal fixation systems, neurostimulation devices, and neurovascular products; its Medical Surgical Portfolio, supplying advanced surgical instruments, energy-based devices, and visualization tools; and its Diabetes Operating Unit, which delivers insulin pumps, continuous glucose monitoring systems, and related consumables. Medtronic plays a significant role in the healthcare sector by providing solutions that support the diagnosis, monitoring, and treatment of complex conditions, serving healthcare providers and patients across the United States, Europe, Japan, and other international markets.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $33.54B | $21.91B | $5.96B | $4.66B | $3.61 |
| 2024 | $32.36B | $21.15B | $5.14B | $3.68B | $2.76 |
| 2023 | $31.23B | $20.51B | $5.49B | $3.76B | $2.82 |
| 2022 | $31.69B | $21.54B | $5.75B | $5.04B | $3.73 |
| 2021 | $30.12B | $19.63B | $4.48B | $3.61B | $2.66 |
| 2020 | $28.91B | $19.49B | $4.79B | $4.79B | $3.54 |
| 2019 | $30.56B | $21.40B | $6.27B | $4.63B | $3.41 |
| 2018 | $29.95B | $20.90B | $6.64B | $3.10B | $2.27 |
| 2017 | $29.71B | $20.42B | $5.38B | $4.03B | $2.89 |
| 2016 | $28.83B | $19.69B | $5.36B | $3.54B | $2.48 |
| 2015 | $20.26B | $13.95B | $3.77B | $2.67B | $2.41 |
| 2014 | $17.00B | $12.67B | $3.81B | $3.06B | $3.02 |
| 2013 | $16.59B | $12.46B | $4.40B | $3.47B | $3.37 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $91.68B | $43.42B | $48.02B | $2.22B | — |
| 2024 | $89.98B | $39.56B | $50.21B | $1.28B | — |
| 2023 | $90.95B | $39.28B | $51.48B | $1.54B | — |
| 2022 | $90.98B | $38.26B | $52.55B | $3.71B | — |
| 2021 | $93.08B | $41.48B | $51.43B | $3.59B | — |
| 2020 | $90.69B | $39.82B | $50.74B | $4.14B | $22.14B |
| 2019 | $89.69B | $39.48B | $50.09B | $4.39B | $24.55B |
| 2018 | $91.39B | $40.57B | $50.72B | $3.67B | $23.69B |
| 2017 | $99.86B | $49.53B | $50.21B | $4.97B | $25.87B |
| 2016 | $99.64B | $47.58B | $52.06B | $2.88B | $29.94B |
| 2015 | $106.69B | $53.45B | $53.23B | $4.84B | $33.17B |
| 2014 | $37.94B | $18.50B | $19.44B | $1.40B | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $7.04B | $1.86B | $5.18B |
| 2024 | $6.79B | $1.59B | $5.20B |
| 2023 | $6.04B | $1.46B | $4.58B |
| 2022 | $7.35B | $1.37B | $5.98B |
| 2021 | $6.24B | $1.35B | $4.88B |
| 2020 | $7.23B | $1.21B | $6.02B |
| 2019 | $7.01B | $1.13B | $5.87B |
| 2018 | $4.68B | $1.07B | $3.62B |
| 2017 | $6.88B | $1.25B | $5.63B |
| 2016 | $5.22B | $1.05B | $4.17B |
| 2015 | $4.90B | $571M | $4.33B |
| 2014 | $4.96B | $396M | $4.56B |

Source: [CompaniesByCap](https://companiesbycap.com/company/MDT)